Sanjay Kaul, MD, FACC, FAHA, is a non-invasive cardiologist, cardiovascular researcher, and academic physician specializing in cardiovascular medicine. He is an Attending Cardiologist at the Smidt Heart Institute at Cedars-Sinai Medical Center and serves as Professor of Medicine at Cedars-Sinai and the David Geffen School of Medicine at UCLA. His clinical focus includes preventive cardiology, cardiometabolic risk management, and noninvasive cardiovascular evaluation. Dr. Kaul’s research interests center on clinical trial methodology and statistical interpretation, cardiometabolic therapeutics and regulatory science, and thrombosis and vascular biology. He has held several leadership roles at Cedars-Sinai, including Director of the Cardiology Fellowship Training Program, Director of the Cardiology Consult Service, and Associate Director of the Coronary Care Unit. Nationally, he has served as a permanent voting member of the FDA Cardiovascular and Renal Drugs Advisory Committee, an advisory panelist for the FDA Endocrine and Metabolic Drugs Advisory Committee, and an editorial board member for the Journal of the American College of Cardiology and Circulation. His honors include a Lifetime Achievement Award from the Cedars-Sinai/VA Greater Los Angeles Cardiovascular Disease Fellowship Program and the Distinguished Physician Award from the American Association of Cardiologists of Indian Origin. He earned his medical degree from Government Medical College, University of Kashmir, completed his residency in internal medicine at Cedars-Sinai Medical Center, and went on to complete a fellowship in cardiovascular disease at the University of Iowa Hospitals and Clinics.
Attending Physician
Medical School
1981 – 1986
Residency
1987 – 1988
Fellowship
1990 – 1993